128 related articles for article (PubMed ID: 26617824)
1. MSH3 rs26279 polymorphism increases cancer risk: a meta-analysis.
Miao HK; Chen LP; Cai DP; Kong WJ; Xiao L; Lin J
Int J Clin Exp Pathol; 2015; 8(9):11060-7. PubMed ID: 26617824
[TBL] [Abstract][Full Text] [Related]
2. Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.
Xia W; Xu Y; Mao Q; Dong G; Shi R; Wang J; Zheng Y; Xu L; Jiang F
Med Oncol; 2015 Feb; 32(2):442. PubMed ID: 25603950
[TBL] [Abstract][Full Text] [Related]
3. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
[TBL] [Abstract][Full Text] [Related]
4. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
5. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
6. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
[TBL] [Abstract][Full Text] [Related]
7. STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of 74,896 subjects.
Xu L; Zhou X; Jiang F; Xu L; Yin R
Cancer Epidemiol; 2014 Apr; 38(2):111-7. PubMed ID: 24252226
[TBL] [Abstract][Full Text] [Related]
8. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.
Tan X; Wang Y; Shi L; Xian L; Guo J; Liang G; Chen M
Genet Test Mol Biomarkers; 2014 Jan; 18(1):50-6. PubMed ID: 24083550
[TBL] [Abstract][Full Text] [Related]
11. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of phospholipase C epsilon 1 polymorphism and cancer risk.
Zhang Y; Wang R; Zhu L; Zhang S; Yuan H; Jiang H
Cancer Biomark; 2013 Jan; 13(6):483-9. PubMed ID: 24595086
[TBL] [Abstract][Full Text] [Related]
13. CRP 1059 G/C and 1846G/A polymorphisms and cancer risk: a meta-analysis of 26,634 subjects.
Zhang Y; Jiang L
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):607-12. PubMed ID: 24835491
[TBL] [Abstract][Full Text] [Related]
14. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
[TBL] [Abstract][Full Text] [Related]
15. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphism of DNA Methyltransferase 3A rs1550117 A>G and Risk of Cancer: A Meta-analysis.
Zhang W; Xu Y; Ma G; Qi W; Gu H; Jiang P
J Invest Surg; 2015; 28(6):346-53. PubMed ID: 26203494
[TBL] [Abstract][Full Text] [Related]
17. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.
Yan Q; Chen P; Lu A; Zhao P; Gu A
PLoS One; 2013; 8(12):e83710. PubMed ID: 24376736
[TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of cancer risk associated with rs2292832 in miR‑149 and rs895819 in miR‑27a: a comprehensive and updated meta‑analysis.
Feng Y; Duan F; Song C; Zhao X; Dai L; Cui S
Oncotarget; 2016 Apr; 7(16):22368-84. PubMed ID: 26993779
[TBL] [Abstract][Full Text] [Related]
19. Associations of ERCC4 rs1800067 polymorphism with cancer risk: an updated meta-analysis.
Yuan Q; Liu JW; Xing CZ; Yuan Y
Asian Pac J Cancer Prev; 2014; 15(18):7639-44. PubMed ID: 25292041
[TBL] [Abstract][Full Text] [Related]
20. The PD-1 rs36084323 A > G polymorphism decrease cancer risk in Asian: A meta-analysis.
Da LS; Zhang Y; Zhang CJ; Bu LJ; Zhu YZ; Ma T; Gu KS
Pathol Res Pract; 2018 Nov; 214(11):1758-1764. PubMed ID: 30249505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
